N4 Pharma Plc (FRA:0GO)
Germany
· Delayed Price · Currency is EUR 0.0010
0.00 (0.00%)
At close: Dec 4, 2025
N4 Pharma Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 0.01 | 0.01 | 0 | - | - | - | Upgrade
|
| Revenue | 0.01 | 0.01 | 0 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 20.60% | 272.86% | - | - | - | - | Upgrade
|
| Gross Profit | 0.01 | 0.01 | 0 | - | - | - | Upgrade
|
| Selling, General & Admin | 0.86 | 0.84 | 0.72 | 0.62 | 0.66 | 0.66 | Upgrade
|
| Research & Development | 0.34 | 0.39 | 0.62 | 0.58 | 1.18 | 0.9 | Upgrade
|
| Operating Expenses | 1.21 | 1.23 | 1.34 | 1.19 | 1.84 | 1.56 | Upgrade
|
| Operating Income | -1.2 | -1.22 | -1.34 | -1.19 | -1.84 | -1.56 | Upgrade
|
| Interest & Investment Income | 0 | - | - | 0 | 0 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | -0.09 | - | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | -1.2 | -1.22 | -1.42 | -1.19 | -1.84 | -1.57 | Upgrade
|
| Pretax Income | -1.2 | -1.22 | -1.42 | -1.19 | -1.84 | -1.57 | Upgrade
|
| Income Tax Expense | -0.07 | -0.1 | -0.15 | -0.16 | -0.3 | -0.26 | Upgrade
|
| Earnings From Continuing Operations | -1.13 | -1.12 | -1.28 | -1.03 | -1.54 | -1.3 | Upgrade
|
| Minority Interest in Earnings | 0.03 | 0.06 | 0.01 | - | - | - | Upgrade
|
| Net Income | -1.1 | -1.06 | -1.27 | -1.03 | -1.54 | -1.3 | Upgrade
|
| Net Income to Common | -1.1 | -1.06 | -1.27 | -1.03 | -1.54 | -1.3 | Upgrade
|
| Shares Outstanding (Basic) | 486 | 340 | 243 | 186 | 181 | 136 | Upgrade
|
| Shares Outstanding (Diluted) | 486 | 341 | 243 | 186 | 181 | 136 | Upgrade
|
| Shares Change (YoY) | 80.86% | 40.34% | 30.29% | 2.95% | 32.85% | 36.08% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | - | - | - | Upgrade
|
| Operating Margin | -17000.69% | -16768.76% | -68377.83% | - | - | - | Upgrade
|
| Profit Margin | -15600.13% | -14537.52% | -64993.91% | - | - | - | Upgrade
|
| EBIT | -1.2 | -1.22 | -1.34 | -1.19 | -1.84 | -1.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.